Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Isopropylbenzene. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2A known ✓ | P08913 | 1/20 | 0.46 |
| ▸ | ADRA2C known ✓ | P18825 | 1/20 | 0.46 |
| ▸ | DPP4 known ✓ | P27487 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | HBB | P68871 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | F2 | P00734 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Isopropylbenzene SCHEMBL27606611 | 1.00 | ALDH1A1 (0.50) | ALDH1A1TAAR1MEN1KMT2AHBB | |
| Isopropylbenzene SCHEMBL28691093 | 0.97 | ALDH1A1 (0.48) | ALDH1A1TAAR1MEN1KMT2AHBB | |
| Isopropylbenzene SCHEMBL29006727 | 0.97 | ALDH1A1 (0.48) | ALDH1A1TAAR1MEN1KMT2AHBB | |
| Isopropylbenzene SCHEMBL4005539 | 0.97 | ALDH1A1 (0.48) | ALDH1A1TAAR1MEN1KMT2AHBB | |
| Isopropylbenzene SCHEMBL3996539 | 0.97 | ALDH1A1 (0.48) | ALDH1A1TAAR1MEN1KMT2AHBB | |
| Isopropylbenzene SCHEMBL23501477 | 0.97 | ALDH1A1 (0.54) | ALDH1A1TAAR1MEN1KMT2AHBB | |
| Isopropylbenzene SCHEMBL8431863 | 0.97 | TAAR1 (0.50) | ALDH1A1TAAR1ADRA2AADRA2CCYP2D6 | |
| Isopropylbenzene SCHEMBL6568 | 0.97 | — | — | |
| Isopropylbenzene SCHEMBL87809 | 0.97 | TAAR1 (0.50) | ALDH1A1TAAR1ADRA2AADRA2CCYP2D6 | |
| Isopropylbenzene SCHEMBL11254813 | 0.97 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1615 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12540295-B2 | Aqueous alkaline abrasive cleaning composition | CONOPCO INC. (US) | 2026-02-03 | — | — | US | claimed |
| EP-4479508-B1 | A FOAMING ACIDIC HARD SURFACE CLEANING COMPOSITION | UNILEVER IP HOLDINGS B V (NL) | 2025-11-05 | — | — | EP | claimed |
| EP-4638676-A1 | A FOAMABLE HARD SURFACE CLEANING COMPOSITION | Unilever IP Holdings B.V. (NL) | 2025-10-29 | — | — | EP | claimed |
| EP-4496874-A1 | A SOLID HARD SURFACE CLEANING COMPOSITION | Unilever IP Holdings B.V. (NL) | 2025-01-29 | — | — | EP | claimed |
| EP-4479508-A1 | A FOAMING ACIDIC HARD SURFACE CLEANING COMPOSITION | Unilever IP Holdings B.V. (NL) | 2024-12-25 | — | — | EP | claimed |
| WO-2024133116-A1 | A FOAMABLE HARD SURFACE CLEANING COMPOSITION | UNILEVER IP HOLDINGS B.V. (NL) | 2024-06-27 | — | — | WO | claimed |
| US-12016334-B2 | Composition comprising sulphated galactose, and implementations thereof | SEA6ENERGY PVT. LTD. (IN) | 2024-06-25 | — | — | US | claimed |
| EP-4244319-B1 | AQUEOUS ALKALINE ABRASIVE CLEANING COMPOSITION | UNILEVER IP HOLDINGS B V (NL) | 2024-06-19 | — | — | EP | claimed |
| WO-2024102612-A1 | COMPOUNDS AND METHODS FOR IDENTIFYING COMPOUNDS FOR MODULATING GLUCOSE TRANSPORT | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2024-05-16 | — | — | WO | claimed |
| EP-4240820-B1 | LIQUID AQUEOUS CLEANING COMPOSITION | UNILEVER IP HOLDINGS B V (NL) | 2024-05-08 | — | — | EP | claimed |
| WO-2001021171-A1 | SYSTEMS FOR AGITATED DELIVERY OF ANTI-INFECTIVE COMPOSITIONS TO TREAT DISORDERED TISSUE SUCH AS COLD SORES | JOHNSON B RON (US) | 2001-03-29 | — | — | WO | claimed |
| WO-2001020981-A2 | ANTI-INFECTIVE COMPOSITIONS FOR TREATING DISORDERED TISSUE SUCH AS COLD SORES | JOHNSON B RON (US) | 2001-03-29 | — | — | WO | claimed |
| WO-2001021170-A1 | SYSTEMS FOR DELIVERING ANTI-INFECTIVE COMPOSITIONS FROM FRANGIBLE AMPULES TO TREAT DISORDERED TISSUE SUCH AS COLD SORES | JOHNSON B RON (US) | 2001-03-29 | — | — | WO | claimed |
| US-6207192-B1 | Prolongation of chemical activity of flavorants and therapeutics with cetyl pyridinium chloride | SDG, INC. | 2001-03-27 | — | — | US | claimed |
| US-5997893-A | ALCOHOL, AN EFFECTIVE AMOUNT OF A CATIONIC ANTIMICROBIAL COMPOUND, AND A CARBOMER | ETHICON, INC. (US) | 1999-12-07 | — | — | US | claimed |
| CN-1228254-A | Alcohol based anti-microbial compositions with cosmetic apparatus | ETHICON INC (US) | 1999-09-15 | — | — | CN | claimed |
| EP-0930065-A2 | Alcohol based anti-microbial compositions with cosmetic appearance | ETHICON, INC. (US) | 1999-07-21 | — | — | EP | claimed |
| CN-1222849-A | Composition, barrier film and method for preventing contact dermatitis | HYDROMER INC (US) | 1999-07-14 | — | — | CN | claimed |
| WO-1998033478-A2 | RNA- AND DNA-BASED ACTIVE AGENTS IN NANOPARTICLES | ZW BIOMEDICAL RESEARCH AG (CH) | 1998-08-06 | — | — | WO | claimed |
| CN-1126071-A | Viracidal, bactericidal and spermicidal vaginal suppository | LAFOR LAB LTD (US) | 1996-07-10 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12016334-B2 | Composition comprising sulphated galactose, and implementations thereof | FUT5, FUT6, ST6GAL1 | ADRA2A 4474/4885ADRA2C 3519/4885DPP4 674/4885 |
| US-12540295-B2 | Aqueous alkaline abrasive cleaning composition | AP3S1, AP2S1, AP3D1 | ADRA2A 4138/4885ADRA2C 2934/4885DPP4 1655/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.